These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31435460)

  • 21. Technological Advances in Charged-Particle Therapy.
    Park JM; Kim JI; Wu HG
    Cancer Res Treat; 2021 Jul; 53(3):635-640. PubMed ID: 34176252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charged-particle therapy for hepatocellular carcinoma.
    Skinner HD; Hong TS; Krishnan S
    Semin Radiat Oncol; 2011 Oct; 21(4):278-86. PubMed ID: 21939857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
    Yoo GS; Yu JI; Park HC
    World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
    Kim TH; Park JW; Kim BH; Oh ES; Youn SH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim DY
    Front Oncol; 2020; 10():542. PubMed ID: 32411594
    [No Abstract]   [Full Text] [Related]  

  • 25. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of External Beam Radiotherapy in Hepatocellular Carcinoma.
    Chen CP
    Clin Liver Dis; 2020 Nov; 24(4):701-717. PubMed ID: 33012454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma.
    Lee SU; Kim TH
    Clin Mol Hepatol; 2023 Oct; 29(4):958-968. PubMed ID: 37822213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Tomizawa K; Shibuya K; Shiba S; Okazaki S; Miyasaka Y; Oishi M; Okamoto M; Ohno T
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1100-1109. PubMed ID: 36870514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
    Yu JI; Park HC; Lim DH; Paik SW
    Cancer Res Treat; 2016 Apr; 48(2):574-82. PubMed ID: 26194367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
    Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study.
    Sorin Y; Ikeda K; Kawamura Y; Fujiyama S; Kobayashi M; Hosaka T; Sezaki H; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Liver Cancer; 2018 Oct; 7(4):323-334. PubMed ID: 30488022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent update of proton beam therapy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Bae SH; Jang WI; Mortensen HR; Weber B; Kim MS; Høyer M
    J Liver Cancer; 2024 Sep; 24(2):286-302. PubMed ID: 38961722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma.
    Shen J; Yan J; Zhu S; Kong W; Zou Z; Liu J; Li S; Liu B
    Front Oncol; 2021; 11():559112. PubMed ID: 34136374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma.
    Shiba S; Shibuya K; Okamoto M; Okazaki S; Komatsu S; Kubota Y; Nakano T; Ohno T
    Radiat Oncol; 2020 Aug; 15(1):195. PubMed ID: 32795340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.
    Gamez ME; Patel SH; McGee LA; Sio TT; McDonald M; Phan J; Ma DJ; Foote RL; Rwigema JM
    Int J Part Ther; 2021; 8(1):131-154. PubMed ID: 34285942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Present status of carbon ion radiotherapy for malignant tumors].
    Sugahara S; Kamada T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton therapy for hepatocellular carcinoma.
    Ling TC; Kang JI; Bush DA; Slater JD; Yang GY
    Chin J Cancer Res; 2012 Dec; 24(4):361-7. PubMed ID: 23359779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
    Kim K; Yu JI; Park HC; Yoo GS; Lim DH; Noh JM; Jeong WK
    Radiother Oncol; 2022 Nov; 176():9-16. PubMed ID: 36113779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma.
    Zaki P; Chuong MD; Schaub SK; Lo SS; Ibrahim M; Apisarnthanarax S
    Technol Cancer Res Treat; 2023; 22():15330338231206335. PubMed ID: 37908130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.